Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149604 | PMC |
| http://dx.doi.org/10.3389/fnagi.2022.919775 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Celebrating the 40th Anniversary of the American Glaucoma Society: Yesterday, Today, and Tomorrow.
Ophthalmol Glaucoma
January 2025
Oklahoma City, Oklahoma.
Differentiation of primary retinal progenitor cells into retinal ganglion-like cells using low dose cytarabine.
Biochem Biophys Res Commun
January 2025
Department of Ophthalmology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Electronic address:
The death of retinal ganglion cells (RGCs) is a key factor in the pathophysiology of all forms of glaucoma. RGC culture serves as a simple system for establishing and testing candidate therapies. This study aimed to explore the differentiation of primary retinal progenitor cells (RPCs) into RGC-like cells induced by low-dose cytarabine (Ara-C).
View Article and Find Full Text PDFPatient Challenges with Glaucoma Eye Drops: A Need to Identify Nonadherence and Facilitate Appropriate Support and Disease Management.
Ophthalmol Glaucoma
January 2025
Portland, Oregon.
Minimally Invasive Glaucoma Surgery and the Distal Aqueous Outflow System: The Final Frontier?
Ophthalmol Glaucoma
January 2025
Baltimore, Maryland.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!